AstraZeneca COVID-19 vaccine trial volunteer has died, Brazil health authority says

United States News News

AstraZeneca COVID-19 vaccine trial volunteer has died, Brazil health authority says
United States Latest News,United States Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 97%

Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University has died, stating it had received data from an investigation into the matter.

The regulator said testing of the vaccine would continue after the volunteer’s death. It provided no further details, citing medical confidentiality of those involved in trials.

The Federal University of Sao Paulo, which is helping coordinate phase 3 clinical trials in Brazil, separately said that the volunteer was Brazilian but did not say where the person lived.The federal government already has plans to purchase the UK vaccine and produce it at its biomedical research center FioCruz in Rio de Janeiro, while a competing vaccine from China’s Sinovac is being tested by Sao Paulo state’s research center Butantan Institute.

Brazil has the second deadliest outbreak of coronavirus, with more than 154,000 killed by COVID-19, following only the United States. It is the third worst outbreak in terms of cases, with more than 5.2 million infected, after the United States and India.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Volunteer In AstraZeneca Covid-19 Vaccine Trial Reportedly Dies In BrazilVolunteer In AstraZeneca Covid-19 Vaccine Trial Reportedly Dies In BrazilThe company’s vaccine trial is currently on hold in the U.S.
Read more »

AstraZeneca close to restarting Covid-19 vaccine trial in U.S.AstraZeneca close to restarting Covid-19 vaccine trial in U.S.AstraZeneca is likely to restart its late-stage U.S. coronavirus vaccine trial 'very soon,' possibly later this week, according to one of the researchers leading the study
Read more »

Mainland China reports 19 new COVID-19 casesMainland China reports 19 new COVID-19 casesChina reported 19 new coronavirus cases in the mainland for Oct. 19, up from 13 cases a day earlier, the health commission said on Tuesday.
Read more »

Britain Moves Toward Ethically Controversial COVID-19 Vaccine TrialBritain Moves Toward Ethically Controversial COVID-19 Vaccine TrialThe British government has announced plans for a coronavirus vaccine challenge trial. Volunteers will receive an experimental vaccine and be exposed to the virus to test its efficacy.
Read more »

More Schools Are Reopening as Covid-19 Cases Rise NationwideMore Schools Are Reopening as Covid-19 Cases Rise NationwideAfter starting school virtually because of the coronavirus pandemic, districts such as Indianapolis, Des Moines and Miami-Dade are opening doors and allowing students back for the first time.
Read more »

WSJ News Exclusive | Some California Hospitals Refused Covid-19 Transfers for Financial Reasons, State Emails ShowWSJ News Exclusive | Some California Hospitals Refused Covid-19 Transfers for Financial Reasons, State Emails ShowSeveral large Southern California hospital systems improperly refused or delayed accepting Covid-19 patients based on their insurance status, according to internal emails, leaving severely ill patients waiting for care and adding strain on hospitals.
Read more »



Render Time: 2025-03-10 03:24:09